about
The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement.Secretogranin II; a protein increased in the myocardium and circulation in heart failure with cardioprotective propertiesIncreased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysisLongitudinal strain is a marker of microvascular obstruction and infarct size in patients with acute ST-segment elevation myocardial infarction.Late gadolinium uptake demonstrated with magnetic resonance in patients where automated PERFIT analysis of myocardial SPECT suggests irreversible perfusion defectAgreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart diseaseImaging of Myocardial Ischemia-Reperfusion Injury Using Sodium [18F]Fluoride Positron Emission Tomography/Computed Tomography in Rats and Humans.Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomographyThird universal definition of myocardial infarction.Comparison of the Cardiac MicroPET Images Obtained Using [(18)F]FPTP and [(13)N]NH3 in Rat Myocardial Infarction Models.Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance.The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigsMetabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction.Cardiac magnetic resonance imaging parameters as surrogate endpoints in clinical trials of acute myocardial infarction.Troponin T levels and infarct size by SPECT myocardial perfusion imagingCardiac-Specific SOCS3 Deletion Prevents In Vivo Myocardial Ischemia Reperfusion Injury through Sustained Activation of Cardioprotective Signaling Molecules.Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathwaysCyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis.Infarct healing is a dynamic process following acute myocardial infarction.TNF-α blockade improves early post-resuscitation survival and hemodynamics in a swine model of ischemic ventricular fibrillation.Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion databaseThe safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction (NITRITE-AMI): study protocol of a randomised controlled trial.New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute WorkshopSample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as Endpoint.Predictors of recovery of left ventricular systolic dysfunction after acute myocardial infarction: from the korean acute myocardial infarction registry and korean myocardial infarction registry.Comparison of wall thickening and ejection fraction by cardiovascular magnetic resonance and echocardiography in acute myocardial infarction.Macrophage migration inhibitory factor for the early prediction of infarct size.Morphine Post-Conditioning Effect on QT Dispersion in Patients Undergoing Primary Percutaneous Coronary Intervention on Anterior Descending Cardiac Artery: A Cohort Study.The role of left ventricular deformation in the assessment of microvascular obstruction and intramyocardial haemorrhageIn vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvascuMRI in acute myocardial infarction.Infarct size reduction in patients with STEMI: why we can do it!Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.Volatile anaesthetics and cardioprotection: lessons from animal studies.Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis.SOCS3: A novel therapeutic target for cardioprotection.The impact of ischemia-reperfusion injury on the effectiveness of primary angioplasty in ST-segment elevation myocardial infarction.Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings.Correlation of electrocardiogram and regional cardiac magnetic resonance imaging findings in ST-elevation myocardial infarction: a literature review.Misinterpretation of the mouse ECG: 'musing the waves of Mus musculus'.
P2860
Q26739737-AC66B2F4-D337-4B94-B606-9D48BBF8375FQ27302632-23559619-8AED-4281-AA6B-6EC584EE2E19Q28568343-60856EDC-C2DE-405C-B932-5395E659AF6DQ30443794-C1DC7ADE-E73C-4B43-9800-EC08A29CA13AQ33392473-C856057E-40EB-4019-8C56-F3251F6A1B62Q33526075-C4C1757E-149B-42D3-8092-87FBCDF7C36FQ33795434-8E3ACD86-8F2C-4708-B5B0-26A3C8BEA73AQ33912094-9EBA9ED4-F007-48D5-9AE3-B4E2E2516C2EQ34295914-BF54630C-17B6-4269-9E9F-7A0C93B1CBC8Q34310203-18DEF2B0-5103-49D9-9BC1-A0321473FD04Q34322273-BEAE199B-BB0F-470F-BF72-1D2111A46694Q35085312-480E92DE-16BB-47BC-A379-1ED6A18A596FQ35149077-9BCD14AB-3F6A-4496-AD28-B5D0B5A56004Q35240779-B08DDB67-9A98-4487-9717-B57DFC6B82C1Q35617332-02A82FC7-82CA-418D-92BF-F052904920EEQ35641335-F7D39129-917E-46BE-B087-9E8C6418EBBBQ35865412-E4A2AF5E-66BF-46BC-B3E3-C49DF78DF8CAQ36147255-550D92CB-DAB7-4ABB-9383-2150BF524DDBQ36237173-04A0A158-8449-4F13-A232-1E1D729E213BQ36390018-27E11AE2-AF0B-46EA-A202-779A497B485BQ36687805-F27787DD-90E6-4A58-BAC8-67611C3B7D03Q36809841-F57679F3-0015-430E-8877-CD4855ECB0ADQ37007953-ED30C5BE-B58C-4F61-8DC6-46A418F1AD32Q37090723-0269747C-1E63-455F-BFB9-8082A9778485Q37168645-5BF1353E-A537-4ACD-80E3-8E98266DBBC8Q37278781-0047EC3D-582D-494D-8BEF-8D2B3C511461Q37328708-2F88F675-E635-458C-AE75-498DCA2B8750Q37641323-A7DA6209-443D-4A21-9F84-E26BE2FAB693Q37692094-B2C2A51E-907B-4712-A937-F11C35134E05Q37733638-88D267F6-7D1A-4197-BB81-3905E17ED4D7Q37812993-D7ABE689-77C0-4DA1-9FDE-94168E639E4DQ37912851-D2D7651A-F6E9-4CB1-8619-FFA590D4FE41Q37912857-CD9CBBF3-8C92-4BC7-BC36-10226DE474EFQ38026951-FE82DD03-A07B-4104-B0DD-CD71F0188A60Q38117307-BEF72ADF-5FE7-4B85-8D7D-7C31D6A582D5Q38140895-9059F4A2-D058-46B9-8A77-634AE39E7F52Q38191219-2F0AE9A7-A3A8-4A00-B276-8C307B727D7FQ38201763-137195E8-9DE3-435C-A942-50F9B144CA29Q38247233-F1C92C47-86D6-4FAC-8827-E14D8DE6D31CQ38254729-9C10E036-3C93-4ADC-889D-9B87C13DBB51
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The quantification of infarct size.
@ast
The quantification of infarct size.
@en
type
label
The quantification of infarct size.
@ast
The quantification of infarct size.
@en
prefLabel
The quantification of infarct size.
@ast
The quantification of infarct size.
@en
P2093
P1476
The quantification of infarct size.
@en
P2093
Allan S Jaffe
Philip A Araoz
Raymond J Gibbons
Uma S Valeti
P304
P356
10.1016/J.JACC.2004.06.071
P407
P577
2004-10-01T00:00:00Z